Molecular regulation of muscle cachexia: It may be more than the proteasome

被引:101
作者
Hasselgren, PO
Wray, C
Mammen, J
机构
[1] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA
[2] Shriners Hosp Children, Cincinnati, OH USA
基金
美国国家卫生研究院;
关键词
muscle; proteolysis; cachexia; ubiquitin; transcription factors; COP9; signalosome; tripeptidyl peptidase II;
D O I
10.1006/bbrc.2001.5849
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Muscle cachexia induced by sepsis, severe injury, cancer, and a number of other catabolic conditions is mainly caused by increased protein degradation, in particular breakdown of myofibrillar proteins. Ubiquitin-proteasome-dependent proteolysis is the predominant mechanism of muscle protein loss in these conditions, but there is evidence that several other regulatory mechanisms may be important as well. Some of those mechanisms are reviewed in this article and they include pre-, para-, and postproteasomal mechanisms. Among preproteasomal mechanisms, mediators, receptor binding, signaling pathways, activation of transcription factors, and modification of proteins are important. Several paraproteasomal mechanisms may influence the trafficking of ubiquitinated proteins and their interaction with the proteasome, including the expression and activity of the COP9 signalosome, the carboxy terminus of heat shock protein 70-interacting protein (CHIP) and valosin-containing protein (VCP). Finally, because the proteasome does not degrade proteins completely into free amino acids but into peptides, postproteasomal degradation of peptides by the giant protease tripeptidyl peptidase II (TPP II) and various aminopeptidases is important in muscle catabolism. Thus, multiple mechanisms and regulatory steps may influence the breakdown of ubiquitinated muscle proteins by the 26S proteasome. (C) 2002 Elsevier Science.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 49 条
[1]   Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? [J].
Andreyev, HJN ;
Norman, AR ;
Oates, J ;
Cunningham, D .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (04) :503-509
[2]  
Attaix D, 1998, ADV MOL CEL, V27, P235, DOI 10.1016/S1569-2558(08)60463-4
[3]  
Auclair D, 1997, AM J PHYSIOL-CELL PH, V272, pC1007
[4]  
BALOW RM, 1983, J BIOL CHEM, V258, P1622
[5]   JAB1/CSN5 and the COP9 signalosome - A complex situation [J].
Chamovitz, DA ;
Segal, D .
EMBO REPORTS, 2001, 2 (02) :96-101
[6]   MUSCLE PROTEOLYSIS INDUCED BY A CIRCULATING PEPTIDE IN PATIENTS WITH SEPSIS OR TRAUMA [J].
CLOWES, GHA ;
GEORGE, BC ;
VILLEE, CA ;
SARAVIS, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (10) :545-552
[7]   The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins [J].
Connell, P ;
Ballinger, CA ;
Jiang, JH ;
Wu, YX ;
Thompson, LJ ;
Höhfeld, J ;
Patterson, C .
NATURE CELL BIOLOGY, 2001, 3 (01) :93-96
[8]   Subtypes of 20S proteasomes from skeletal muscle [J].
Dahlmann, B ;
Ruppert, T ;
Kloetzel, PM ;
Kuehn, L .
BIOCHIMIE, 2001, 83 (3-4) :295-299
[9]   Valosin-containing protein is a multiubiquitin chain targeting factor required in ubiquitin-proteasome degradation [J].
Dai, RM ;
Li, CCH .
NATURE CELL BIOLOGY, 2001, 3 (08) :740-744
[10]   Involvement of valosin-containing protein, an ATPase co-purified with IκBα and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IκBα [J].
Dai, RM ;
Chen, EY ;
Longo, DL ;
Gorbea, CM ;
Li, CCH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3562-3573